This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Jan;47(1):61-4.

doi: 10.5414/cpp47061.

Pharmacokinetics of sorafenib in patients with renal impairment undergoing hemodialysis

R A Hilger¹, H Richly, M Grubert, S Kredtke, D Thyssen, W Eberhardt, J Hense, M Schuler, M E Scheulen

Affiliations

PMID: 19203541
DOI: 10.5414/cpp47061

Pharmacokinetics of sorafenib in patients with renal impairment undergoing hemodialysis

R A Hilger et al. Int J Clin Pharmacol Ther. 2009 Jan.

. 2009 Jan;47(1):61-4.

doi: 10.5414/cpp47061.

Authors

R A Hilger¹, H Richly, M Grubert, S Kredtke, D Thyssen, W Eberhardt, J Hense, M Schuler, M E Scheulen

Affiliation

¹ Department of Internal Medicine, University of Essen Medical School, Essen, Germany. ralf.hilger@uni-duisburg-essen.de

PMID: 19203541
DOI: 10.5414/cpp47061

No abstract available

PubMed Disclaimer

Similar articles

Clinical results and pharmacokinetics of sorafenib in chronic hemodialysis patients with metastatic renal cell carcinoma in a single center.
Kennoki T, Kondo T, Kimata N, Murakami J, Ishimori I, Nakazawa H, Hashimoto Y, Kobayashi H, Iizuka J, Takagi T, Yoshida K, Tanabe K. Kennoki T, et al. Jpn J Clin Oncol. 2011 May;41(5):647-55. doi: 10.1093/jjco/hyr015. Epub 2011 Mar 2. Jpn J Clin Oncol. 2011. PMID: 21367805
Sorafenib and sunitinib.
Kim A, Balis FM, Widemann BC. Kim A, et al. Oncologist. 2009 Aug;14(8):800-5. doi: 10.1634/theoncologist.2009-0088. Epub 2009 Aug 1. Oncologist. 2009. PMID: 19648603 Free PMC article. Review. No abstract available.
Sorafenib.
Rini BI. Rini BI. Expert Opin Pharmacother. 2006 Mar;7(4):453-61. doi: 10.1517/14656566.7.4.453. Expert Opin Pharmacother. 2006. PMID: 16503817 Review.
Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study.
Shinsako K, Mizuno T, Terada T, Watanabe J, Kamba T, Nakamura E, Ogawa O, Inui K. Shinsako K, et al. Int J Clin Oncol. 2010 Oct;15(5):512-4. doi: 10.1007/s10147-010-0070-9. Epub 2010 Mar 26. Int J Clin Oncol. 2010. PMID: 20340037
Sorafenib - a small molecule with big promise?
Tadmor T, Tallman MS, Polliack A. Tadmor T, et al. Leuk Lymphoma. 2010 Feb;51(2):181-2. doi: 10.3109/10428190903470893. Leuk Lymphoma. 2010. PMID: 20001865 No abstract available.

See all similar articles

Cited by

Efficacy of innovative systemic treatments in combination with radiotherapy for bone metastases: a GEMO (the European Study Group of Bone Metastases) state of the art.
Gueiderikh A, Faivre JC, Golfier C, Escande A, Thureau S. Gueiderikh A, et al. Cancer Metastasis Rev. 2025 Jan 29;44(1):28. doi: 10.1007/s10555-024-10236-0. Cancer Metastasis Rev. 2025. PMID: 39875680 Free PMC article. Review.
Interaction Between Sex and Organic Anion-Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib-N-Oxide and Regorafenib-Glucuronide in Mice.
Fu Q, Chen M, Anderson JT, Sun X, Hu S, Sparreboom A, Baker SD. Fu Q, et al. Clin Transl Sci. 2019 Jul;12(4):400-407. doi: 10.1111/cts.12630. Epub 2019 Apr 6. Clin Transl Sci. 2019. PMID: 30955241 Free PMC article.
Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide.
Bins S, van Doorn L, Phelps MA, Gibson AA, Hu S, Li L, Vasilyeva A, Du G, Hamberg P, Eskens F, de Bruijn P, Sparreboom A, Mathijssen R, Baker SD. Bins S, et al. Clin Transl Sci. 2017 Jul;10(4):271-279. doi: 10.1111/cts.12458. Epub 2017 Mar 31. Clin Transl Sci. 2017. PMID: 28371445 Free PMC article. Clinical Trial.
Sustained response following sorafenib therapy in an older adult patient with advanced renal cancer on hemodialysis: a case report.
Castagneto B, Stevani I, Giorcelli L, Montefiore F, Bigatti GL, Pisacco P, Cosimi MF. Castagneto B, et al. Med Oncol. 2011 Dec;28(4):1384-8. doi: 10.1007/s12032-010-9595-z. Epub 2010 Jun 15. Med Oncol. 2011. PMID: 20552299
Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges.
Yeh H, Chiang CC, Yen TH. Yeh H, et al. World J Gastroenterol. 2021 Jul 14;27(26):4104-4142. doi: 10.3748/wjg.v27.i26.4104. World J Gastroenterol. 2021. PMID: 34326614 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information